🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to contact these profiles directly for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where communities with thousands of participants share comparison images, injection guides and assertions of next-day British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have warned that the sale of what remains an unapproved drug in the UK is worrisome and could result in users administering products of uncertain source.

Several experts said the demand for the experimental drug could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, marketing, and customer regulations, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Content Removal

According to TikTok, the service has taken down problematic content and banned associated keywords and search suggestions. The company said it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Investigations also discovered groups with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with numerous of users, filled with images of slimming results, glowing reviews and step-by-step guides for preparing or injecting at home.

After moments of joining one community, a vendor shared WhatsApp details, where most transactions take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about body mass, health issues or previous experience.

Item Details and Pricing

Within these groups, posts show dark colored packages with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for Telegram said it actively monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these online versions may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has already encountered patients harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may expose patients to potentially serious health risks”.